In the News

410 News Items found
GSK Dean Michael Overholtzer stands at the podium
Event
Memorial Sloan Kettering’s 42nd annual ceremony recognized graduates and award winners with a virtual ceremony.
A lab coat with an MSK logo hangs on a hook
Fourteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 14, 2025, as part of Memorial Sloan Kettering’s 46th annual academic convocation.
Scientists Jan Remsik, Adrienne Boire, and Jessica Wilcox in the lab
Finding
The presence of inflammatory molecules in the cerebrospinal fluid appears to be causing many of the neurologic effects seen in people with COVID-19.
Medical oncologist Bill Tap examines a patient
Feature
Spend a day with the expert team in MSK's world-renowned sarcoma service.
A researcher working in an MSK lab
MSK Research Highlights, March 26, 2025
New MSK research develops a new tool for studying mitochondrial DNA deletions; uncovers mechanisms of histiocytosis-associated neurodegeneration; and investigates how mutant stem cells co-opt regeneration to make tumors grow.
Linde Miles
Q&A
Dr. Miles is a postdoctoral fellow in the Human Oncology and Pathogenesis Program at MSK studying the genetics of blood cancers.
MSK Kids neuroblastoma patient Abby Hawk
Get to know Abby Hawk, who got a tattoo of Memorial Sloan Kettering after being treated there for neuroblastoma.
Michael Roehrl
A new resource provides a comprehensive list of human proteins that could trigger autoimmune symptoms in ‘long COVID’ patients.
Scientists at Memorial Sloan Kettering Cancer Center (MSK) announced that they have built a new model of genetically engineered immune cells in mice that may allow them to fight solid tumors.
Epithelial cells
In the Lab
New findings from researchers at the Sloan Kettering Institute provide insight into a fundamental biological process called the epithelial-mesenchymal transition.